WHO ICTRP trial
The effect of dexmedetomidine after craniotomy in sedation and its complication
IRCT20170716035104N2 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20170716035104N2 |
|---|---|
| Public title | The effect of dexmedetomidine after craniotomy in sedation and its complication |
| Scientific title | The effect of dexmedetomidine infusion after craniotomy on sedation and its complications in the intensive care unit and its comparison with the control group |
| Primary sponsor | Esfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Craniotomy. Cranial nerve disorder, unspecified;G52.9 |
| Interventions | Intervention 1: After the completion of the surgery, the intervention group will receive a dose of 1 microgram per kilogram of body weight diluted in a volume of 20 ml for 10 minutes and a repeated dose of half a microgram per kilogram of… |
| Registration date | Apr 21, 2019 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: